EICHOR
● Recruiting
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Condition: Prostate Cancer · Sponsor: Astellas Pharma Global Development, Inc.
About this study
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.
This description comes directly from the study's public registry record.
Talk to the study team
Astellas Pharma Global Development · 800-888-7704 · astellas.registration@astellas.com
Always discuss trial participation with your own doctor first.
Locations (241)
| Site US10052 | Anchorage, Alaska, United States | Completed |
| Site US10011 | Tucson, Arizona, United States | Completed |
| Site US10040 | Los Angeles, California, United States | Completed |
| Site US10009 | Los Angeles, California, United States | Completed |
| Site US10067 | Orange, California, United States | Recruiting |
| Site US10008 | San Bernardino, California, United States | Completed |
| Site US10042 | San Diego, California, United States | Completed |
| Site US10028 | Stanford, California, United States | Completed |
| Site US10001 | Aurora, Colorado, United States | Completed |
| Site US10017 | Denver, Colorado, United States | Completed |
| Site US10050 | Washington D.C., District of Columbia, United States | Completed |
| Site US10049 | Daytona Beach, Florida, United States | Completed |
+ 229 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02960022